His research has focused on the development and testing of innovative treatments for depressive and bipolar disorders including medications, medication combinations, somatic treatments, psychotherapy, and disease management protocols.[3] Rush's work is widely recognized nationally and internationally, and has received awards from many professional organizations including the American College of Psychiatrists, American Psychopathological Association the National Alliance for Research in Schizophrenia and Affective Disorders, the American Psychiatric Association and the Society for Biological Psychiatry, among others.[3] In 2014, Thomson Reuters recognized Dr. Rush as one of the “World’s Most Influential Scientific Minds”